Search Results - "Mazzarella, Brian C"

Urinary comprehensive genomic profiling predicts urothelial carcinoma recurrence and identifies responders to intravesical therapy by Rac, Goran, Patel, Hiten D., James, Christopher, Desai, Shalin, Caruso, Vincent M., Fischer, Daniel S., Lentz, Peter S., Ward, Ceressa T., Mazzarella, Brian C., Phillips, Kevin G., Doshi, Chirag, Bicocca, Vincent T., Levin, Trevor G., Wolfe, Alan J., Gupta, Gopal N.

“…Intravesical therapy (IVT) is the standard of care to decrease risk of recurrence and progression for high‐grade nonmuscle‐invasive bladder cancer. However,…”
Get full text

Development and multicenter case-control validation of urinary comprehensive genomic profiling for urothelial carcinoma diagnosis, surveillance, and risk prediction by Salari, Keyan, Sundi, Debasish, Lee, Jason J, Wu, Shulin, Wu, Chin-Lee, DiFiore, Gabrielle, Yan, Q Robert, Pienkny, Andrew, Lee, Chi K, Oberlin, Daniel, Barme, Greg, Piser, Joel, Kahn, Robert, Collins, Edward, Phillips, Kevin G, Caruso, Vincent M, Goudarzi, Mahdi, Garcia-Ransom, Monica, Lentz, Peter S, Evans-Holm, Martha E, MacBride, Andrew R, Fischer, Daniel S, Haddadzadeh, Iden J, Mazzarella, Brian C, Gray, Joe W, Koppie, Theresa M, Bicocca, Vincent T, Levin, Trevor G, Lotan, Yair, Feldman, Adam S

“…Urinary comprehensive genomic profiling (uCGP) uses next-generation sequencing to identify mutations associated with urothelial carcinoma (UC) and has the…”
Get full text

Decreasing need for artificial urinary sphincter revision surgery by precise cuff sizing in men with spongiosal atrophy by Simhan, Jay, Morey, Allen F, Zhao, Lee C, Tausch, Timothy J, Scott, J Francis, Hudak, Steven J, Mazzarella, Brian C

“…Many patients with persistent incontinence after an artificial urinary sphincter procedure gain improved continence after cuff downsizing. In 2010 a new,…”
Get more information

Minimal Residual Disease Detection with Urine-derived DNA Is Prognostic for Recurrence-free Survival in Bacillus Calmette-Guérin–unresponsive Non–muscle-invasive Bladder Cancer Treated with Nadofaragene Firadenovec by Narayan, Vikram M., Tholomier, Come, Mokkapati, Sharada, Martini, Alberto, Caruso, Vincent M., Goudarzi, Mahdi, Mazzarella, Brian C., Phillips, Kevin G., Bicocca, Vincent T., Levin, Trevor G., Yla-Herttuala, Seppo, McConkey, David J., Dinney, Colin P.N.

“…In patients with bacillus Calmette-Guérin–unresponsive non–muscle-invasive bladder cancer, urine DNA profiling identifies those with the greatest likelihood of…”
Get full text

Urinary Comprehensive Genomic Profiling Correlates Urothelial Carcinoma Mutations with Clinical Risk and Efficacy of Intervention by Bicocca, Vincent T., Phillips, Kevin G., Fischer, Daniel S., Caruso, Vincent M., Goudarzi, Mahdi, Garcia-Ransom, Monica, Lentz, Peter S., MacBride, Andrew R., Jensen, Brad W., Mazzarella, Brian C., Koppie, Theresa, Korkola, James E., Gray, Joe W., Levin, Trevor G.

“…The clinical standard of care for urothelial carcinoma (UC) relies on invasive procedures with suboptimal performance. To enhance UC treatment, we developed a…”
Get full text

Clinical utility of urinary comprehensive genomic profiling in diagnosing metachronous upper tract urothelial carcinoma: a case report by Yonover, Paul M., Ward, Ceressa T., Mazzarella, Brian C., Phillips, Kevin G., Jensen, Brad W., Bicocca, Vincent T., Duffy, Kathleen, Yonover, Jaden, Cherry, Ava, Levin, Trevor G.

“…Introduction and aim of study Metachronous upper tract urothelial carcinoma (UTUC) is a rare yet aggressive malignancy that is often multifocal and invasive at…”
Get full text

MP16-07 URINARY MINIMAL RESIDUAL DISEASE DETECTION PREDICTS RECURRENCE IN BCG-UNRESPONSIVE NIMBC AND QUANTIFIES MOLECULAR RESPONSE TO NADOFARAGENE FIRADENOVEC by Narayan, Vikram M., Tholomier, Come, Mokkapati, Sharada, Martini, Alberto, Caruso, Vincent M., Mazzarella, Brian C., Phillips, Kevin G., Bicocca, Vincent T., Levin, Trevor G., Sawutz, David, Yla-Herttuala, Seppo, Parker, Nigel, McConkey, David J., Dinney, Colin P. N.

Get full text

Urinary minimal residual disease detection predicts recurrence in BCG-unresponsive NIMBC and quantifies molecular response to nadofaragene firadenovec by Narayan, Vikram M, Tholomier, Come, Mokkapati, Sharada, Martini, Alberto, Caruso, Vincent M., Mazzarella, Brian C., Phillips, Kevin G., Bicocca, Vincent T., Levin, Trevor G., Yla-Herttuala, Seppo, Sawutz, David, Parker, Nigel, McConkey, David James, Dinney, Colin P.N.

“…635 Background: Urinary minimal residual disease (uMRD) profiling uses next-generation sequencing to identify mutations associated with urothelial carcinoma…”
Get full text

Comprehensive genomic profiling of urine DNA for urothelial carcinoma detection and risk prediction by Salari, Keyan, Lee, Jason J., Bicocca, Vincent T., Caruso, Vincent, Mazzarella, Brian C., Phillips, Kevin G., Levin, Trevor G., Feldman, Adam S.

“…Abstract only 450 Background: Clinical diagnosis and risk stratification of patients with urothelial carcinoma (UC) remains a challenge, with high rates of…”
Get full text

PD46-07 URINARY COMPREHENSIVE GENOMIC PROFILING AIDS IN DETECTION AND RISK PROGNOSIS OF UPPER TRACT UROTHELIAL CARCINOMA: A CASE-CONTROLLED COHORT STUDY by Yonover, Paul, Kaplinsky, Robert, Salari, Keyan, Feldman, Adam, Sundi, Debasish, Phillips, Kevin G., Fisher, Daniel, Cherry, Ava, Mazzarella, Brian C., Bicocca, Vincent T., Gray, Joe, Koppie, Theresa M., Levin, Trevor G., Cohen, Justin

Get full text

PD12-10 URINE COMPREHENSIVE GENOMIC PROFILING OF UROTHELIAL CARCINOMA PATIENTS UNDERGOING INTRAVESICAL THERAPY ENABLES DETECTION OF ACTIONABLE DNA MUTATIONS ASSOCIATED WITH DRUG RESPONSE AND RISK STRATIFICATION by Rac, Goran, Desai, Shalin, Patel, Hiten D., Doshi, Chirag, Dornbier, Ryan, Caruso, Vincent, Lentz, Peter, Mazzarella, Brian C., Phillips, Kevin G., Levin, Trevor, Wolfe, Alan J., Gupta, Gopal N.

Get full text

MP54-09 URINE COMPREHENSIVE GENOMIC PROFILING PREDICTS RECURRENCE IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER TREATED WITH INTRAVESICAL THERAPY by Rac, Goran, Desai, Shalin, Patel, Hiten D., Doshi, Chirag, Dornbier, Ryan, Caruso, Vincent, Lentz, Peter, Mazzarella, Brian C., Phillips, Kevin G., Levin, Trevor, Wolfe, Alan J., Gupta, Gopal N.

Get full text

DETECTION, RISK STRATIFICATION, AND THERAPUETIC SELECTION FOR UPPER TRACT UROTHELIAL CARCINOMA WITH URINE-BASED COMPREHENSIVE GENOMIC PROFILING by Yonover, Paul M., Kaplinsky, Robert, Cherry, Ava, Yonover, Jaden, Cohen, Justin J., Salari, Keyan, Feldman, Adam, Sundi, Debasish, Phillips, Kevin G., Fischer, Daniel, Mazzarella, Brian C., Bicocca, Vincent T., Ward, Ceressa T., Levin, Trevor G., Gray, Joe W., Koppie, Theresa M., Agarwal, Gautum

“…Upper tract urothelial carcinoma (UTUC) is a rare and aggressive malignancy that is difficult to diagnose and stage. A urine test capable of detecting UTUC…”
Get full text